Literature DB >> 8129772

Nomenclature and classification of vasculitis: plus ça change, plus c'est la même chose.

J T Lie.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 8129772     DOI： 10.1002/art.1780370205

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  27 in total

Review 1.  Immunopathological aspects of systemic vasculitis.

Authors:  I M Bajema; E C Hagen; F Ferrario; E de Heer; J A Bruijn
Journal:  Springer Semin Immunopathol       Date:  2001

2.  A prospective study of vasculitis patients collected in a five year period: evaluation of the Chapel Hill nomenclature.

Authors:  S F Sørensen; O Slot; N Tvede; J Petersen
Journal:  Ann Rheum Dis       Date:  2000-06       Impact factor: 19.103

Review 3.  Primary and secondary vasculitic neuropathy.

Authors:  Gérard Said; Catherine Lacroix
Journal:  J Neurol       Date:  2005-04-05       Impact factor: 4.849

Review 4.  Classification of the vasculitides: are they clinically useful?

Authors:  Ana M Bertoli; Graciela S Alarcón
Journal:  Curr Rheumatol Rep       Date:  2005-08       Impact factor: 4.592

5.  A new international classification of childhood vasculitis.

Authors:  Michael J Dillon; Seza Ozen
Journal:  Pediatr Nephrol       Date:  2006-07-04       Impact factor: 3.714

Review 6.  Mixed cryoglobulinemia as a model of systemic vasculitis.

Authors:  F Dammacco; D Sansonno
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

7.  EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides.

Authors:  S Ozen; N Ruperto; M J Dillon; A Bagga; K Barron; J C Davin; T Kawasaki; C Lindsley; R E Petty; A M Prieur; A Ravelli; P Woo
Journal:  Ann Rheum Dis       Date:  2005-12-01       Impact factor: 19.103

Review 8.  Nomenclature and classification of vasculitis - update on the ACR/EULAR diagnosis and classification of vasculitis study (DCVAS).

Authors:  R A Luqmani; R Suppiah; P C Grayson; P A Merkel; R Watts
Journal:  Clin Exp Immunol       Date:  2011-05       Impact factor: 4.330

Review 9.  Pulmonary vasculitis: classification, clinical features, and management.

Authors:  A Ciaccia; M Ferrari; F M Facchini; G Caramori; L Fabbri
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

10.  Anti-Nuclear Cytoplasmic Antibody-Associated Vasculitis: A Probable Adverse Effect of Sofosbuvir Treatment in Chronic Hepatitis C Patients.

Authors:  Youssef K Ahmad; Salwa Tawfeek; Mohamed Sharaf-Eldin; Hassan E Elbatea; Abdelrahman Kobtan; Ferial El-Kalla; Rehab Badawi; Sherief Abd-Elsalam
Journal:  Hosp Pharm       Date:  2017-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.